IDENTIFICATION OF PHYTOCHEMICAL MODULATORS OF MULTI-Drug RESISTANCE PROTEIN 5 (MRP5)

被引：0
|
作者：
Li, Yan [1 ]
Revalde, Jezrael [1 ]
Reid, Glen [2 ]
Paxton, James W. [1 ]
机构：
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand
[2] Univ Sydney, Asbestos Dis Res Inst, Bernie Banton Ctr, Sydney, NSW 2006, Australia
来源：
DRUG METABOLISM REVIEWS | 2010年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：295 / 295
页数：1
相关论文
共 50 条
  • [21] Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1)
    Matsunaga, Seita
    Asano, Takeshi
    Tsutsuda-Asano, Arisa
    Fukunaga, Yoshitaka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (03) : 348 - 353
  • [22] Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart
    Dazert, P
    Meissner, K
    Vogelgesang, S
    Heydrich, B
    Eckel, L
    Böhm, M
    Warzok, R
    Kerb, R
    Brinkmann, U
    Schaeffeler, E
    Schwab, M
    Cascorbi, I
    Jedlitschky, G
    Kroemer, HK
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04): : 1567 - 1577
  • [23] Immunohistochemical study of MRP5 expression in meningiomas
    George A. Alexiou
    Ann Goussia
    Antigoni Ntoulia
    Panagiota Zagorianakou
    Vasiliki Malamou-Mitsi
    Spyridon Voulgaris
    Athanasios P. Kyritsis
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 825 - 828
  • [24] Immunohistochemical study of MRP5 expression in meningiomas
    Alexiou, George A.
    Goussia, Ann
    Ntoulia, Antigoni
    Zagorianakou, Panagiota
    Malamou-Mitsi, Vasiliki
    Voulgaris, Spyridon
    Kyritsis, Athanasios P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 825 - 828
  • [25] Contribution of multidrug resistance protein MRP5 in control of cyclic guanosine 5′-monophosphate intracellular signaling in anterior pituitary cells
    Andric, Silvana A.
    Kostic, Tatjana S.
    Stojilkovic, Stanko S.
    ENDOCRINOLOGY, 2006, 147 (07) : 3435 - 3445
  • [26] Role of multidrug resistance protein-5 (MRP5) in the control of cGMP-mediated pial arteriolar dilation in the rat
    Xu, HL
    Santizo, RA
    Pelligrino, DA
    FASEB JOURNAL, 2003, 17 (04): : A62 - A62
  • [27] Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
    E A Roundhill
    S A Burchill
    British Journal of Cancer, 2012, 106 : 1224 - 1233
  • [28] Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
    Roundhill, E. A.
    Burchill, S. A.
    BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1224 - 1233
  • [29] The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes
    Minich, T
    Riemer, J
    Schulz, JB
    Wielinga, P
    Wijnholds, J
    Dringen, R
    JOURNAL OF NEUROCHEMISTRY, 2006, 97 (02) : 373 - 384
  • [30] Sepsis affects cardiac expression of multidrug resistance protein 5 (MRP5, ABCC5), an ABC-type cGMP export pump
    Meissner, Konrad
    Kessler, Wolfram
    Meyer zu Schwabedissen, Henriette E.
    Jedlitschky, Gabriele
    Grube, Markus
    Saalfeld, Kay
    Schuster, Katharina
    Buck, Anna
    Traeger, Tobias
    Meier, Stefan
    Heidecke, Claus-Dieter
    Lehmann, Christian
    Kroemer, Heyo K.
    CIRCULATION, 2006, 114 (18) : 770 - 770
12345